In another study, the synergistic use of FUS and brain-penetrating polymeric nanoparticles, delivering glial cell line derived neurotrophic factor (GDNF) in animal PD models, increased GDNF levels in the target region, providing lasting improvement of neural transmission in that area. Here, GDNF is linked to Parkinson disease.